Share with others! EyeMelanoma.org gets you quickly to the info & resources you need
Share with others! EyeMelanoma.org gets you quickly to the info & resources you need
>> CURE OM's 14th "Eyes on a Cure: Patient & Caregiver Symposium"
When: April 5–6, 2025
Where: Cleveland, Ohio (and Online)
Save the Date (A link to further information will be provided once available)
CLICK ON AN OCULAR MELANOMA CONFERENCE BELOW TO SEE THE LIST OF PRESENTATIONS, NAMES OF PRESENTERS, AND VIDEO LINKS.
Links to presentations will be added when they are posted on the internet by conference host.
Medical Presentations:
• Uveal Melanoma Basic Science Research
(Andrew Aplin, PhD; 00:14:20 time stamp; 30 minutes)
• Current Management of Uveal Melanoma
(Dr. Sara Lally; 00:47:00 time stamp; 45 minutes)
Medical Presentations:
• Risk Assessment and Follow-Up of Uveal Melanoma
(Dr. Rino Seedor; 0:00 time stamp; 15 minutes)
• Neo-Adjuvant and Adjuvant Treatment for High-Risk Primary Uveal Melanoma
(Dr. Rino Seedor; 21:00 time stamp; 20 minutes)
• Systemic Treatments for Metastatic Uveal Melanoma
(Dr. Marlana Orloff; 43:00 time stamp; 30 minutes)
• Multidisciplinary Care, Early Diagnosis & Imaging, and the Rationale for Liver-Directed Treatments for Metastatic Uveal Melanoma
(Dr. Robert Adamo; 1:14:00 time stamp; 25 minutes)
• Immunoembolization and Percutaneous Hepatic Perfusion as Treatment for Metastatic Uveal Melanoma
(Dr. David Eschelman; 1:39:00 time stamp; 20 minutes)
• Radioembolization & Chemoembolization of Uveal Melanoma Hepatic Metastases
(Dr. Carin Gonsalves; 2:00:00 time stamp; 25 minutes)
• The Role of Radiation for Metastatic Uveal Melanoma
(Dr. Pramila Rani Anne; 2:24:00 time stamp; 15 minutes)
Presentations from non-profit OM patient organizations about their activities and services [also posted on EyeMelanoma.org's Organizations webpage] and a presentation introducing the Sidney Kimmel Cancer Center OM Program's nursing, patient navigator, and administrative staff (video total: 90 minutes)
Medical Presentation:
• Participating in Ocular Melanoma Clinical Trials [the process plus Q&A]
(Melanoma Research Team Nurse Manager Tina Savio, Assistant Director for Research Operations Katherine Senter, and Dr. Takami Sato; 0:00 time stamp; 60 minutes)
Video 1
Medical Presentation:
• Moving Towards Cure: A New Chapter for Patients with Uveal Melanoma
(Dr. Richard Carvajal; link preset at 3:45 time stamp; 30 minutes)
Video 2
Medical Presentations:
• Update on Uveal Melanoma Registries
(Prof. Anthony Joshua; link preset at 0:40 time stamp; 15 minutes)
• IDEAYA Biosciences: Darovasertib Clinical Development for Ocular Melanoma
(Dr. Darrin Beaupre; link preset at 30:29 time stamp; 10 minutes)
Video 3
Medical Presentations:
• Tebentafusp – What You Need to Know as an Ocular Melanoma Patient
(Prof. Anthony Joshua; link preset at 0:00 time stamp; 20 minutes)
• Targeting GNAQ and GNA11 in Uveal Melanoma
(Assoc. Prof. Matteo Carlino; link preset at 18:52 time stamp; 15 minutes)
Video 4
Medical Presentations:
• Uveal Melanoma Testing: Options, Interpretation, and Access Pathways
(Prof. Svetlana Cherepanoff; link preset at 0:00 time stamp; 15 minutes)
• Circulating Tumour DNA as a Biomarker in Uveal Melanoma
(Dr. Aaron Beasley; link preset at 15:44 time stamp; 10 minutes)
Video 5
Medical Presentations:
• How We Work Up Uveal Melanoma: An Ophthalmologist’s Perspective for Patients
(Dr. Tim Isaacs; link preset at 0:00 time stamp; 20 minutes)
• Artificial Eyes in Rehabilitation of Ocular Melanoma Patients
(Ocularist Jenny Geelen; link preset at 22:30 time stamp; 20 minutes)
Video 6
Medical Presentation:
• Advances in Radiation Treatment of Uveal Melanoma — Australia's New South Wales Experience
(Dr. Wenchang Wong; link preset at 14:15 time stamp; 20 minutes)
Video 7
Medical Presentation:
(Dr. Joseph Sacco; link preset at 0:00 time stamp; 30 minutes)
All videotaped presentations from this conference
The time stamp info below shows where you will find the specific presentation within the video.
Medical Presentations:
• Ocular Melanoma: Diagnosis, Biopsies, and Proton Irradiation
(Dr. Frances Wu; 1:20:00 time stamp; 20 minutes)
• Plaque Brachytherapy and Gamma Knife for Ocular Melanoma Patients
(Dr. Shilpa Desai; 1:44:00 time stamp; 15 minutes)
• What to Expect After Radiation for Uveal Melanoma
(Dr. Ivana Kim; 1:58:00 time stamp; 40 minutes)
• Ocular Melanoma Surveillance and Adjuvant Treatment
(Dr. Ryan Sullivan; 2:37:00 time stamp; 45 minutes)
Medical Presentations:
• Overview of Metastatic Treatment Approaches in Uveal Melanoma
(Dr. Kamaneh Montazeri; 3:00 time stamp; 25 minutes)
• Tebentafusp in Practice for Ocular Melanoma Patients
(Dr. Ryan Sullivan; 30:29 time stamp; 35 minutes)
• Liver-Directed Therapies for Ocular Melanoma Patients
(Dr. Eric Wehrenberg-Klee; 1:06:00 time stamp; 25 minutes)
• Targeted Systemic Therapies for Uveal Melanoma
(Dr. Rizwan Haq; 1:33:00 time stamp; 25 minutes)
• Immunotherapies for Metastatic Uveal Melanoma
(Dr. Elizabeth Buchbinder; 1:59:00 time stamp; 20 minutes)
Medical Presentation:
• Changes in Sexual Health During and After Ocular Melanoma Cancer Treatment
(Cristina Pozo-Kaderman, PhD; 22:00 time stamp; 40 minutes)
Medical Presentation:
• Oncology Nutrition Fact Versus Fiction
(Christina Conte, Registered Dietician; 1:22:00 time stamp; 60 minutes)
Conference's Science Sunday Video
Medical Presentations:
• The Potential for Circulating Biomarkers in Uveal Melanoma
(Dr. Ryan Sullivan; 57:00 time stamp; 35 minutes)
• Liver Metastases in Ocular Melanoma: Some New Research That I Am Excited About
(Dr. Rizwan Haq; 1:35:00 time stamp; 35 minutes)
Medical Presentations:
• A Look at the UK Uveal Melanoma Guidelines & Ocular Melanoma
(Dr. Matthew Wheater; 40 minutes)
• Can Precision Medicine Identify New Opportunities in Ocular Melanoma?
(Dr. Tim Crook; 30 minutes)
• Latest Ocular Melanoma Research Developments and Clinical Trials
(Professor Jeff Evans; 30 minutes)
• What Are Ocular Melanoma Clinical Trials and Why Are They So Important?
(Dr. Archana Bansal; 20 minutes)
• What Is ctDNA and Can It Help Us Start Ocular Melanoma Treatment Early
(Professor Mark Middleton; 40 minutes)
All videotaped presentations from this conference
Medical Presentations:
• Biology of Cancer and Uveal Melanoma
(Lucinda Innes, PhD; Dr. Andrew Stacey; and Dr. Dennis Stacey; 55 minutes)
• INSIGHT Patient Registry for Ocular Melanoma: What Is It and Why Do We Need One?
(ACIS's Melody Burchett and Hanna Hulick, and patient Kevin; 50 minutes)
• Integrative Medicine and Ocular Melanoma
(Dr. Blake Langley; 60 minutes)
• Ocular Melanoma Metastatic Disease 101
(Dr. Julia Brechbiel, Dr. Evan Hall, Lucinda Innes, PhD student; 85 minutes)
• Ocular Prosthetics 101: Design and Care
(Ocularists Todd and Tawnya Cranmore; 65 minutes)
• Ocular Melanoma Treatments and Side Effects
— How to Choose a Treatment (Dr. Elaine Binkley)
— Dry Eye Disease After Radiation (Dr. Minh Nguyen)
— A Brief Overview of Eye Removal Surgery (Dr. Andrew Stacey)
(total 45 minutes)
• Palliative Care and Hospice Care in Ocular Melanoma — When to Call Who?
(Dr. Ted Dropcho; 55 minutes)
• Radiation Basics for Ocular Melanoma
— Radiation Retinopathy (Dr. Chris Bowen)
— Radiation: What Is It and How Does It Work (Dr. Jonathan Chen)
(total 60 minutes)
• Research Does Not Equal a Cure — What Brings an Ocular Melanoma Drug to Market?
(Lucinda Innes, PhD; Dr. Steven Katz; Christian Wade, PhD; and patient Kevin; 60 minutes)
• Your Prognosis at Ocular Melanoma Diagnosis
(Dr. Shailender Bhatia, Dr. Julia Brechbiel, and Dr. Andrew Stacey; 60 minutes)
All videotaped presentations from this conference
Medical Presentation:
• Uveal Melanoma: Where We Are and Where We Are Going
(Dr. Marlana Orloff; 45 minutes)
Medical Presentations:
• Uniting the Ocular Melanoma Community: Keeping Our Eyes on A Cure [Including Latest Information on VISION Patient Registry]
(Dr. Sara Selig; 45 minutes)
• Development of the Ocular Oncology Clinical Nurse Consultant Role: Impact on Ocular Melanoma Patient Care
(Clinical Nurse Peta Holly; 10 minutes)
Medical Presentations:
• Determinants of PKC Inhibitor Response in Uveal Melanoma
(Professor Helen Rizos; 15 minutes)
• Drug Discovery and Development in Human Uveal Melanoma
(Associate Professor Fanfan Zhou; 15 minutes)
• Improving Plaque Brachytherapy for Uveal Melanoma
(Honorary Researcher Jeremy Flanagan; 15 minutes)
• Q&A
(All Video 3 Presenters; 5 minutes)
Medical Presentations:
• How Do Optometrists Manage Choroidal Melanocytic Lesions?
(Associate Professor Michelle Madigan; 15 minutes)
• Uveal Melanoma Tumour Biopsy: South Australia Experience
(Dr. David Sia; 10 minutes)
• Uveal Melanomas: South Australia Pathology Experience
(Dr. Amardeep Gilhotra; 10 minutes)
• An Update on Proton Therapy for Ocular Melanoma in Australia and Clinical Application
(Associate Professor Peter Gorayski; 20 minutes)
• The Incidence and Mortality of Conjunctival Melanoma in Australia
(Dr. Aaron Beasley; 15 minutes)
• Q&A
(All Video 4 Presenters; 10 minutes)
Medical Presentations:
• Locoregional Therapies for Metastatic Uveal Melanoma
(Professor Roger Olofsson Bagge; 30 minutes)
• Genomics and Prognostication in Uveal Melanoma
(Dr. Emine Kilic; 35 minutes)
• Q&A
(All Video 5 Presenters; 15 minutes)
Medical Presentations:
• Primary Disease: Intra-Ocular Melanocytic Lesions
(Dr. Ezekiel Weis; 40 minutes)
• Estimation of Metastatic Risk in Uveal Melanoma
(Dr. Hatem Krema; 55 minutes)
• Genomic Testing for Uveal Melanoma
(Castle Biosciences' Katherina Alsina, PhD, 15 minutes)
• Uveal Melanoma Prognostic Tumor Test
(Impact Genetics' Jaime Jessen, Certified Genetic Counselor; 10 minutes)
Medical Presentations:
• Metastatic Uveal Melanoma
(Dr. Marcus Butler; 45 minutes)
Presentations by patients are also included in each day's video.
All presentations are provided together in a 6-hour video by the conference hosts. The time stamp info below shows where you will find the specific presentation within the video.
Medical Presentations:
• Ocular Melanoma: Biology, Epidemiology, Diagnosis, and Local Treatment
(Dr. Andrew Stacey; 9:40 time stamp; 50 minutes)
• Proton Therapy for Ocular Melanoma: Continued Innovation
(Dr. Lia Halasz; 1:00:45 time stamp; 35 minutes)
• Systemic Therapy Options for Advanced Ocular Melanoma: Past, Present, and Future
(Dr. Evan Hall; 1:38:15 time stamp; 40 minutes)
• Liver-Directed Therapies for Metastatic Ocular Melanoma
(Dr. Wayne Monsky; 2:17:00 time stamp; 30 minutes)
• Predicting Metastasis in Uveal Melanoma: A Research Update
(Dr. Alison Skalet; 2:46:30 time stamp; 65 minutes)
• Managing Fear of Recurrence for Ocular Melanoma Patients
(Dr. Julia Brechbiel; 4:31:30 time stamp; 25 minutes)
• Genetic Testing for Inherited Cancer Risks for Ocular Melanoma Patients
(Lauren Facchini, Genetic Counselor; 4:54:30 time stamp; 20 minutes)
Medical Presentations:
Primary Ocular Melanoma
• Ocular Melanoma Past, Present, and Future
(Dr. William Harbour; 45 minutes)
(Dr. Basil Williams; 30 minutes)
• Prognostication and Ocular Care After Treatment of Uveal Melanoma
(Dr. Zelia Correa; 30 minutes)
• Q&A About Primary Ocular Melanoma
(Panel of Presenters; 10 minutes)
Metastatic Ocular Melanoma
• Current Clinical Trials for Metastatic Uveal Melanoma
(Dr. Nikhil Khushalani; 25 minutes)
• Current Status of Systemic Therapy for Uveal Melanoma
(Dr. Ahmad Tarhini; 20 minutes)
• High-Risk Uveal Melanoma and Adjuvant Therapies
(Dr. Jose Lutzky; 30 minutes)
• Liver-Directed Therapies for Metastatic Uveal Melanoma
(Dr. David Eschelman; 60 minutes)
• Q&A About Uveal Melanoma Systemic Treatment & Metastatic Disease
(Panel of Presenters; 20 minutes)
Primary and Metastatic
• A Field of Hope: Ocular Melanoma Research Updates and Discussion
(Keiran Smalley, PhD; Dr. Alison Skalet; Florian Karreth, PhD; and David Morse, PhD; 70 minutes)
All videotaped presentations from this conference
IN ORDER TO HIGHLIGHT THE LATEST INFORMATION ON ALL TOPICS, ONLY OCULAR MELANOMA CONFERENCE PRESENTATIONS MADE DURING THE PAST TWO YEARS STAY LISTED ON THIS WEBPAGE EACH MONTH
New information added to this webpage: October 23, 2024
Links to all external sites re-verified on this webpage: May 2, 2024
Any Feedback? Email: Erica@EyeMelanoma.org
EyeMelanoma.org, a not-for-profit website, does not contain any advertisements and does not accept funding/donations.
Medical Disclaimer: This site is for informational purposes only and does not provide medical advice.
Copyright © 2011–2024. EYEMELANOMA.ORG. All Rights Reserved.
EyeMelanoma.org has been providing current information on ocular melanoma since 2011.
This not-for-profit website does not contain any advertisements and does not accept funding/donations.
Google Analytics is used within this site to determine the number of visitors. Data is anonymous.